BioSpace News Archive

The target action date for the completion of the FDA’s review of the new drug application for TX-004HR is May 29, 2018.

Diversigen will serve as a central lab for the generation of high quality microbiome data to be incorporated into the Crohn’s & Colitis Foundation’s IBD Plexus® platform

New CVS Health initiative seeks to solve one of the nation’s most pressing problems and a major source of consumer financial worry

Mylan acquires exclusive license to commercialize in Europe

Extracellular Matrix Device Designed to Reinforce Soft Tissue in a Range of Implantable Settings

--Team Led by Nationally-Known Biotech and Natural Foods Entrepreneurs Launches BiomeBlissTM, First-in-Class Product to Nourish, Shift and Protect the GI Microbiome-- --Scientifically-Developed Blend of Prebiotic and Other Natural Ingredients in Convenient, Tasty Low-Calorie Drink Format Now Available to Consumers Nationwide--

Launching one of the first SEC-compliant ICO security offerings

Social Security numbers are coming off Medicare cards beginning April 1 but Massachusetts residents won’t see their new cards for several months

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a regular quarterly dividend of 40 cents per share, an increase of 6.7 percent over the year-ago period.

New larger Hybrid Cocoons provide production excitement